NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
CC E-029-2011-2-CN-05 Therapeutic Apparatus And Method For Heating A Subject CN National Stage 2011849379 Pending
CC E-029-2011-2-PCT-01 Therapeutic Apparatus And Method For Heating A Subject PCT PCT COMB PCT/IB11/054485 Expired
NCI E-239-2011-0-US-01 Thioxothiazolidinone Derivatives Useful As Inhibitors Of Tdp1 US 61/545,308 Abandoned
NIAID E-050-1997-1-US-17 DEVICE HAVING REGIONS OF DIFFERING AFFINITIES TO FLUID, METHODS OF MAKING SUCH DEVICES, AND METHODS OF USING SUCH DEVICES US CON 13/269,226 Abandoned
NCI E-217-2011-0-US-01 Genetic Marker For Predicting Prognosis In Patients Infected With Hepatitis C Virus US 61/543,620 Abandoned
NCI E-197-2011-0-US-01 Use Of MiRNA126 To Produce Hemapoietic Stem Cells US 61/542,468 Abandoned
NCI E-239-2010-0-EP-05 Manipulation of Stem Cell Function By P53 Isoforms EP National Stage 11771334.7 Abandoned
NCI E-239-2010-0-AU-03 Manipulation of Stem Cell Function By P53 Isoforms AU National Stage 2011308567 Abandoned
NIAID E-001-1996-0-US-08 NEUTRALIZING MONOCLONAL ANTIBODIES TO RESPIRATORY SYNCYTIAL VIRUS US DIV 13/250,357 8221759 Expired PDF
NCI E-239-2010-0-PCT-02 Manipulation of Stem Cell Function By P53 Isoforms PCT PCT PCT/US2011/054304 Expired
NCATS E-258-2010-0-PCT-02 COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF TREATING OR PREVENTING NEURODEGENERATIVE DISEASES OR DISORDERS PCT PCT PCT/US2011/54325 Expired
NICHD E-271-2011-0-US-01 Influenza Vaccine US 61/541,942 Abandoned
NCI E-239-2010-0-CA-04 Manipulation of Stem Cell Function By P53 Isoforms CA National Stage 2812300 Abandoned
NIDCR E-018-2009-1-US-06 Differentially Expressed MicroRNAs As Biomarkers For the Diagnosis and Treatment of Sjogrens Syndrome US National Stage 13/262,125 8785414 Abandoned PDF
NINDS E-144-2010-0-US-02 Therapeutic Approach To Neurodegenerative Disorders Using A TFP5-peptide US ORD 13/249,003 8597660 Issued PDF
NIDCR E-232-2011-0-US-01 Methods for the Diagnosis And Treatment Of Sjogren's Syndrome US 61/540,364 Abandoned
NINDS E-249-2011-0-US-01 Method of Treating Multiple Sclerosis By Intrathecal Administration of RitUximab And Biomarkers TO Select Patients With Progressive Multiple Sclerosis US 61/539,870 Abandoned
NCI E-147-2012-0-US-01 Methods Of Treating Periodontal Inflammation And Periodontal Bone Loss US 61/539,315 Abandoned
NIA E-012-2012-0-US-01 COMBINATION THERAPY USING IMMUNOGLOBULIN AND C1-INHIBITOR US 61/538,832 Abandoned
NIAID E-292-2010-2-EP-03 NOVEL HIV-1 BROADLY NEUTRALIZING ANTIBODIES EP National Stage 11827599.9 Issued
NICHD E-023-2002-0-US-04 Methods of using Bacillus Anthracis Protective Antigen Sequences For Vaccination US DIV 13/244,060 8703150 Expired PDF
NCI E-296-2008-0-US-03 Anti-Cancer Oligodeoxynucleotides US CON 13/243,841 8697666 Abandoned PDF
NCATS E-240-2011-0-PCT-01 Galactokinase Inhibitors For The Treatment And Prevention Of Associated Diseases And Disorders PCT PCT PCT/US2011/053021 Expired
NIAID E-292-2010-2-PCT-01 NOVEL HIV-1 BROADLY NEUTRALIZING ANTIBODIES PCT PCT COMB PCT/US2011/052933 Expired
NIAID E-154-2011-2-US-01 Immune Based Treatment For Influenza US 61/538,427 Abandoned
NIAID E-293-2011-0-US-01 Self-Assembled Ferritin Nanoparticles Expressing Hemagglutinin As An Influenza Vaccine US 61/538,663 Abandoned
NIAID E-120-2001-0-US-18 DEVELOPMENT OF MUTATIONS USEFUL FOR ATTENUATING DENGUE VIRUSES AND CHIMERIC DENGUE VIRUSES US DIV 13/240,849 8632782 Expired PDF
NCI E-064-2008-2-US-06 Epoxy-guaiane Derivatives And Treatment of Cancer US National Stage 12/811,245 8410292 Issued PDF
NHLBI E-259-2003-0-US-26 METHODS FOR SUPPRESSING AN IMMUNE RESPONSE OR A TREATING A PROLIFERATIVE DISORDER US DIV 13/241,008 Abandoned
NIAID E-004-2009-2-US-05 Virus-Like Particles (VLPS) Prepared from Chikungunya Virus Structural Proteins US National Stage 13/131,287 9353353 Issued PDF
NCI E-317-2008-0-US-02 Renal Cell Carcinoma Biomarkers US National Stage 13/257,580 8790869 Abandoned PDF
NEI E-110-2005-2-NZ-22 USE OF IL-23 AND IL-17 ANTAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE NZ DIV 595262 Abandoned
NIDCR E-280-2011-0-US-01 Inhibition Of Metastasis with ROCK Inhibitors US 61/536,434 Abandoned
NICHD E-202-2010-0-US-01 Anisotropic Phantom For Calibration, Validation, And QA Of Quantitative MRI Measurements US 61/536,032 Abandoned
NHGRI E-244-2010-0-PCT-02 GRM3 Mutations And Uses Thereof For The Diagnosis And Treatment of Melanoma PCT PCT PCT/US2011/052032 Expired
NCI E-171-2010-1-US-06 HIV-l ANTIBODIES US National Stage 13/496,811 Abandoned
NICHD E-226-2010-0-US-01 Tractography Based Transit Time Determination US 61/535,851 Abandoned
NCI E-263-2011-0-US-01 PSEUDOMONAS EXOTOXIN A WITH LESS IMMUNOGENIC B CELL EPITOPES US 61/535,668 Abandoned
NIMH E-225-2011-0-US-01 Beta-amyloid Imaging Agents, Methods Of Manufacture, and Methods of Use Thereof US 61/535,569 Abandoned
NHLBI E-108-2010-0-EP-03 Methods and Devices For Transcatheter Cerclage Annuloplasty EP National Stage 11760945.3 Abandoned
NHLBI E-108-2010-0-PCT-02 Devices For Transcatheter Cerclage Annuloplasty PCT PCT PCT/US2011/51748 Expired
NCI E-266-2011-0-US-01 T CELL RECEPTORS RECOGNIZING HLA-A1-OR HLA-CW7-RESTRICTED MAGE US 61/535,086 Abandoned
NCI E-269-2010-0-CA-04 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE CA National Stage 2811788 Issued
NCI E-269-2010-0-EP-05 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE EP National Stage 11763819.7 Issued
NCI E-269-2010-0-IE-22 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE IE EP 11763819.7 Issued
NCI E-269-2010-0-IT-23 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE IT EP 11763819.7 Issued
NCI E-269-2010-0-FR-20 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE FR EP 11763819.7 Issued
NCI E-269-2010-0-DE-18 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE DE EP 11763819.7 Issued
NCI E-269-2010-0-AT-15 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE AT EP 11763819.7 Issued
NCI E-269-2010-0-BE-16 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE BE EP 11763819.7 Issued